Company Long-Term Loans and Borrowings: iTeos (ITOS)

Public company logo of iTeos Therapeutics Inc (ITOS)

iTeos Therapeutics (ITOS) generates revenue by developing anti-tumor agents, receiving payments and royalties from GSK for the joint implementation of antibodies. However, geopolitical conflicts and reagent shortages are slowing down drug certification. Meanwhile, the company strictly adheres to laboratory waste disposal regulations. This price chart confirms these data, where the debt load stands at 0.01, reflecting the current financial state of the business.

ITOS iTeos Therapeutics Company Long-Term Debts (07/04/2022 - 09/14/2025)

iTeos (ITOS) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price iteostherapeutics.com|ITOS - Price Target Chart
- company stock exchange capitalization indicators:
Market Value iTeos Therapeutics|ITOS - Total Company Value
- book capitalization information:
Accounting Value per Share iTeos Therapeutics|ITOS - Book Capitalization|Market Capitalization to Book Value Ratio iteostherapeutics.com|ITOS - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio iTeos Therapeutics|ITOS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient iTeos Pharma|ITOS - Company Debts|Debt to Book Value iTeos Therapeutics|ITOS - Company Long-Term Debt|Company Current Liabilities iTeos Therapeutics
Analysis of all company metrics:ITOS - iteostherapeutics.com
Brand item of iTeos Therapeutics

This indicator determines the long-term debt load, which is critical for assessing the issuer's solvency. The metric aggregates all liabilities with a maturity exceeding one year, revealing the resilience of the capital structure. By analyzing the long-term debt level of the company, an investor sees the real cost of borrowed financing. The stability of this figure confirms the financial discipline of iTeos Therapeutics (ITOS). This correlates with their strict adherence to ethical norms and ESG standards in onco-immunology.

Competitors of iTeos Therapeutics (ITOS)

Company Long-Term Debts argenx.com ARGX|BNTX - Company Long-Term Debt|Company Long-Term Loans and Borrowings ABVX (abivax.com)|ADMA Bio (ADMA) - Company Long-Term Debt|Company Long-Term Liabilities Protagonist Corp|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com|Company Long-Term Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CLDX (Celldex)|Long-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|Company Long-Term Liabilities ABCL|Company Long-Term Debts Tourmaline|Company Long-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Long-Term Indebtedness|Company Long-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Long-Term Debt|Zenas Biopharma, Inc. - Company Long-Term Debts|Long-Term Debt Volume Immunome Bio IMNM|GOSS (Gossamer Bio, Inc.) - Company Long-Term Liabilities|KALV: Amount of Long-Term Liabilities|SEPN (Septerna) - Company Long-Term Debts|Long-Term Debt Pieris Pharma PVLA|Company Long-Term Debt Savara Corp (SVRA)|RIGL - Long-Term Debt|Company Long-Term Debt AnaptysBio, Inc. ANAB|Long-Term Debt Volume astriatx.com (ATXS)|ENGN: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings RAPT (rapt.com)|JBIO (aerovatetx.com) - Company Long-Term Liabilities|ACRS: Amount of Long-Term Liabilities|KYTX (Kyverna Therapeutics) - Company Long-Term Debts|TLSA: Company Long-Term Loans and Borrowings|Company Long-Term Debts CABA|VTYX - Long-Term Debt|Company Long-Term Debt Theratechnologies Inc THTX|Company Long-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Long-Term Debts|AGEN - Company Long-Term Debts|Climb Bio (CLYM) - Company Long-Term Debt|Long-Term Liabilities ZURA (zurabio.com)|ATYR (aTyr) - Company Long-Term Debts|Long-Term Debt Adagene Corp ADAG|Company Long-Term Liabilities IMA (ImageneBio Inc)|Company Long-Term Debts shattucklabs.com (STTK)|Equillium - Company Long-Term Liabilities|Amount of Long-Term Liabilities CNTB (Connect Biopharma Holdings)|Immunic Inc - Company Long-Term Debts|Long-Term Debt Volume Atara Biotherapeutics ATRA|IFRX: Company Long-Term Debts|Company Long-Term Liabilities x4pharma.com|Company Long-Term Debt Adicet Bio Inc.|Celularity Corp (CELU) - Long-Term Debt Volume|Company Long-Term Debts INMB|Long-Term Debt Volume Barinthus Biotherapeutics Corp|Kezar Life Sciences - Company Long-Term Liabilities|Amount of Long-Term Liabilities SABS (sabbiotherapeutics.com)|AKTX - Company Long-Term Debt|Long-Term Debt Enlivex Therapeutics|q32bio.com (QTTB) - Company Long-Term Debt|GOVX - Long-Term Debt Volume|Company Long-Term Debt Edesa Biotech, Inc.|ibioinc.com - Long-Term Liabilities|Company Long-Term Debts CARM|XTLB (XTL Biopharmaceuticals Ltd) - Company Long-Term Loans and Borrowings|Company Long-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Long-Term Debts HCW Biologics, Inc. HCWB|APVO - Company Long-Term Debt|Company Long-Term Loans and Borrowings AIM (aimimmuno.com)|aditxt.com (ADTX) - Company Long-Term Debt|Company Long-Term Liabilities GRI Bio Inc|XRTX (XORTX) - Company Long-Term Debts|Company Long-Term Debts Vyome Therapeutics|Company Long-Term Liabilities REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Long-Term Debt Volume CalciMedica Inc (CALI)|AFMD - Company Long-Term Debt|Allakos Inc. (ALLK) - Company Long-Term Liabilities|hookipapharma.com (HOOK) - Company Long-Term Debt|Company Long-Term Liabilities IGM Biosciences|Company Long-Term Liabilities OCEA|Company Long-Term Debts TC BioPharm (Holdings) Plc|Company Long-Term Debt Third Harmonic Bio, Inc (THRD)